4826 | It has been a while but I am back. | kaiser | 09/28/2025 5:45:13 PM |
4254 | SHMX 0004 X 0005 company should have an update | kaiser | 02/18/2015 11:28:00 AM |
4253 | SHMX 0006 hitting | kaiser | 02/17/2015 1:57:36 PM |
4252 | SHMX 0005 X 0006 | kaiser | 02/17/2015 1:38:29 PM |
4251 | SHMX 0004 X 0005 bid building | kaiser | 02/17/2015 12:13:57 PM |
4250 | SREH 0005 hitting | kaiser | 02/17/2015 11:05:54 AM |
4249 | SHMX 0004 X 0005 | kaiser | 02/17/2015 10:24:03 AM |
4248 | SHMX 0004 falling | kaiser | 02/17/2015 10:20:54 AM |
4247 | SHMX 0004 hitting | kaiser | 02/17/2015 10:16:35 AM |
4246 | KHGT 0013 | kaiser | 02/17/2015 9:34:07 AM |
4245 | SHMX 0003 X 0004 | kaiser | 02/17/2015 9:31:42 AM |
4244 | SREH 0005 company filings out last week. Company | kaiser | 02/17/2015 8:10:14 AM |
4243 | SREH 0004 X 0005 bid building | kaiser | 02/13/2015 3:01:25 PM |
4242 | SREH 0005 hitting | kaiser | 02/13/2015 2:32:10 PM |
4241 | CATA 0024 X 0026 | kaiser | 02/13/2015 2:19:35 PM |
4240 | KHGT 0017 X 0018 | kaiser | 02/13/2015 1:58:13 PM |
4239 | KHGT 0016 nice buys coming in | kaiser | 02/13/2015 1:56:14 PM |
4238 | LGBS 0005 | kaiser | 02/13/2015 11:00:30 AM |
4237 | LGBS 0004 hitting | kaiser | 02/13/2015 10:58:41 AM |
4236 | LGBS 0003 buyers moving in | kaiser | 02/13/2015 10:56:02 AM |
4235 | MCGI 0022 hitting | kaiser | 02/12/2015 3:48:58 PM |
4234 | CATA 002 X 0022 | kaiser | 02/12/2015 2:41:14 PM |
4233 | CATA 0016 X 0022 | kaiser | 02/12/2015 1:39:48 PM |
4232 | CATA 0019 | kaiser | 02/12/2015 1:09:12 PM |
4231 | CATA 0017 | kaiser | 02/12/2015 1:03:42 PM |
4230 | CATA 0014 X 0016 | kaiser | 02/12/2015 1:00:59 PM |
4229 | EVDR 0007 hitting | kaiser | 02/12/2015 12:23:31 PM |
4228 | EVDR 0006 X 0007 | kaiser | 02/12/2015 11:59:07 AM |
4227 | SREH 0005 hitting | kaiser | 02/12/2015 11:29:09 AM |
4226 | CATA 0014's going | kaiser | 02/12/2015 10:21:27 AM |
4225 | CATA 0014 nice hits coming in | kaiser | 02/11/2015 3:30:01 PM |
4224 | EVDR 0006 nice buying | kaiser | 02/11/2015 3:05:32 PM |
4223 | CATA 0011 X 0014 bidders moving | kaiser | 02/11/2015 2:49:50 PM |
4222 | CATA 0014 | kaiser | 02/11/2015 2:27:05 PM |
4221 | CATA 0013 buys coming in | kaiser | 02/11/2015 2:24:31 PM |
4220 | VOIS 0016 | kaiser | 02/11/2015 1:51:36 PM |
4219 | VOIS 0015 hitting | kaiser | 02/11/2015 1:47:58 PM |
4218 | MCGI 0016 X 0019 nice bid in | kaiser | 02/11/2015 1:40:28 PM |
4217 | VOIS 0014 X 0015 | kaiser | 02/11/2015 12:35:04 PM |
4216 | TOPZ 0016 nice buying. Looks | kaiser | 02/11/2015 12:21:56 PM |
4215 | VOIS 0014 | kaiser | 02/11/2015 11:58:07 AM |
4214 | VOIS 0012 X 0013 | kaiser | 02/11/2015 10:27:18 AM |
4213 | VOIS 0011 X 0012 | kaiser | 02/11/2015 10:09:21 AM |
4212 | VOIS 0011 | kaiser | 02/11/2015 9:33:29 AM |
4211 | MCGI 002 | kaiser | 02/10/2015 1:36:21 PM |
4210 | VOIS 0011 X 0012 | kaiser | 02/10/2015 12:12:54 PM |
4209 | VOIS 0011's going | kaiser | 02/10/2015 12:06:52 PM |
4208 | CATA 0013 getting some volume | kaiser | 02/10/2015 11:42:33 AM |
4207 | VOIS 0011 hitting | kaiser | 02/10/2015 11:35:14 AM |
4206 | MCGI 0019 | kaiser | 02/10/2015 11:34:06 AM |
4205 | VOIS 001 X 0011 | kaiser | 02/10/2015 10:34:45 AM |
Recent Articles
- Antengene Advances ATG-022: Promising Clinical Outcomes Revealed
- Investigation Announcement for Baxter International Investors
- Cytokinetics Investors: Secure Representation Before Deadline
- Jasper Therapeutics Investors: Important Class Action Deadline Ahead
- Mesoblast Limited Reports Significant Revenue Growth After Ryoncil Launch
- CStone Pharmaceuticals Shares Promising Phase I Results for CS2009
- Ascletis Completes Enrollment in Phase IIa Study of ASC30.
- Innovations in Pancreatic Cancer Treatment with Satri-cel
- Cambodia's Techo International Airport: A Gateway to Growth
- Record Growth in Q2 Revenues Enhances Mesoblast's Market Position
- Faraday Future's Vision: Accelerating Towards FX Super One Launch
- IZERVAY™ Delivers Long-Term Benefits for Geographic Atrophy Patients
- Clover Biopharmaceuticals Names Nicholas Jackson as President
- Dr. Luke Wainscoat Brings Expertise to The Brattle Group
- Kering and L'Oréal Unite to Transform Luxury Beauty Sector
- Kering and L’Oréal: A New Era in Luxury Beauty and Wellness
- Kering Partners with L'Oréal to Transform Luxury Beauty Sector
- Alice Walton and Elon Musk: Giants of Wealth in 2025
- Clarins and V Magazine Host a Glamorous Golden Hour Event
- Sobi Adjusts Revenue Forecast for 2025 Amid Strong Q3 Growth
- Sobi Updates Full-Year Outlook and Q3 2025 Financial Report
- Exploring NB HASH and the Transformation of Wealth Today
- Kevin Hart's Journey From Investment Missteps to Business Success
- BlackRock's Strategic Shift: The Future of Investment in RWA
- Major Contract Termination Announced by Vantage Drilling
- Deadline Approaches for Dow Inc. Investors Amid Legal Action
- Important Update for Cepton, Inc. Investors on Class Action
- Target and Walmart Thrive Amid Collectible Card Sales Surge
- Snap Investors Urged to Consider Leading Legal Action
- Unlocking Wealth Potential: The RWA Revolution Explained
- Embracing Real-World Assets with NB HASH for Sustainable Growth
- Nutex Health Investors Can Join Class Action Against Company
- Potential Legal Action for Baxter International Investors
- Solidarity in Aviation: Airline Workers Support Controllers
- Class Action Lawsuit Against MoonLake Immunotherapeutics Investors
- Promising Outcomes Unveiled from HARMONi-6 Clinical Study
- Exploring Cadonilimab's Promising Results in Advanced Gastric Cancer
- Tech Giants Reshape Manufacturing Strategies Amid Market Shifts
- Promising Findings on Subcutaneous Amivantamab for Cancer
- Vivace Therapeutics Reports Promising Results for VT3989 Therapy
- iOncologi's Patent Enhances Cancer Treatment with mRNA Breakthrough
- Innovative Subcutaneous Therapy Shows Promise in Cancer Treatment
- New Breakthrough Data from Novartis on Prostate Cancer Treatment
- Transforming Assets: The Role of NB HASH in Digital Wealth
- The Future of Wealth: Bridging Real-World Assets with Blockchain
- Avacta Therapeutics Reveals Promising Phase 1a Results for FAP-Dox
- Significant Phase 1a Trial Findings for Faridoxorubicin
- Major Developments in AI: Insights from Top Tech Executives
- Celebrating Five Years of Innovations at United Imaging's Hub
- International Engagement Highlighted at Financial Forum 2025